Esgic-Plus (Butalbital / Acetaminophen / Caffeine) - Summary

ESGIC-PLUS SUMMARY

ESGIC-PLUS^TM CAPSULES
Butalbital, Acetaminophen and Caffeine Capsules, USP
50 mg/500 mg/40 mg

Butalbital, acetaminophen and caffeine is supplied in capsule form for oral administration. Butalbital (5-allyl-5-isobutylbarbituric acid), a slightly bitter, white, odorless, crystalline powder, is a short to intermediate-acting barbiturate.

Butalbital, Acetaminophen and Caffeine Capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.

Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.

ESGIC-PLUS NEWS HIGHLIGHTS

Clinical Trials Related to Esgic-Plus (Butalbital / Acetaminophen / Caffeine)

A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1 [Active, not recruiting]

A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 [Active, not recruiting]

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis [Completed]

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM) [Completed]

Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer [Recruiting]

more>>